Recent research has shown that dynamin-related protein 1 (Drp1)-mediated aberrant 48 mitochondrial fission plays an important role in dopaminergic nerve cell apoptosis. 49 However, the upstream regulatory mechanism remains unclear. Our study shows that Parkinson's disease (PD), which often occurs in elderly patients, is a 63 neurodegenerative disease characterized by dopamine deficiency caused by 64 nigrostriatal dopaminergic nerve cell apoptosis. With the continued aging of the 65 population, the incidence of PD increases yearly 1 . As the pathogenesis remains 66 obscure, therapeutic options of PD are mainly symptomatic therapies and levodopa 67 (L-DOPA) remains the most effective drug since the 1960s 2 . However, long-term 68 administration of L-DOPA has limited clinical applications due to the adverse side 69 effects with long-term use 3 . Therefore, the molecular mechanism of nigrostriatal 70 dopaminergic nerve cell apoptosis needs to be elucidated and is of great significance 71 for improving therapeutic strategies for the treatment of PD. symptoms 5,9-12 . Drp1 is a GTPase; once Drp1 is activated, Drp1 translocates from the 87 cytosol to the outer mitochondrial membrane (i.e., mitochondrial translocation), forms 88 a ring structure around the mitochondria and changes the distance and angle of 89 molecules, gradually compressing the mitochondria until they are fractured by GTP 90 hydrolysis, resulting in fission of mitochondria followed by cytochrome c (Cyto C) 91 release and caspase activation, and eventually leading to apoptosis [13] [14] [15] [16] . However, the 92 upstream regulatory mechanism of Drp1-mediated mitochondrial fission in PD has 93 not yet been explored. 94 Rho-associated coiled-coil protein kinase 1 (ROCK1) is a member of the Ras 95 protein family with a molecular weight of 160 kDa, and plays important regulatory 96 role in cancer cell growth and survival, as well as invasion and metastasis of 97 neoplasm 17 . In the field of cancer research, ROCK1 has been reported to be cleaved 98 into activated ROCK1 with a molecular weight of 130 kDa through proteolytic 99 cleavage of its C-terminal auto-inhibitory domain, which eventually leads to 100 apoptosis 18 . Importantly, activated ROCK1 has been found to play an important role 101 in regulating mitochondrial fission via dephosphorylation/activation of Drp1 in 102 human breast cancer cells 19 . Additionally, there are also reports in the central nervous 103 system that the specific ROCK1 activation inhibitor Y-27632 decreases dopaminergic 104 nerve cell death in mice and primary neuron-glia cultures 20,21 , but the mechanisms 105 remain elusive. Based on the above, we propose that ROCK1 may be involved in the 106 pathogenesis of PD as an important upstream regulator of Drp1. 107 In the present study, we confirm that Drp1-mediated aberrant mitochondrial 108 6 fission participates in the pathogenesis of PD. Furthermore, we evaluated the role of 109 ROCK1 in regulating dopaminergic nerve cell apoptosis in PD. We found that 110 ROCK1 is activated in PD, and ROCK1 knockdown or pretreatment with the ROCK1 increase in dephosphorylation at Ser 656) was detected in the cells exposed to MPP + 210 ( Fig. 5c ). To further confirm these findings, we stably knocked down ROCK1 using a 211 11 lentivirus shRNA approach (Fig. 5d ). We next investigated whether ROCK1 (Fig. 7c, d) . The results of TH expression detected by western blot analysis 248 were consistent with that of immunohistochemical staining (Fig. 7e ). All of these 249 findings suggest that our MPTP-induced PD mouse model was successfully 250 established and that inhibition of ROCK1 activation using Y-27632 can protect 251 dopamine nerve cells from the MPTP-mediated dopamine depletion in this in vivo 252 model. 253 We next examined the mechanism underlying PD in vivo. Immunohistochemical 254 and western blot analysis showed that injection with Y-27632 before MPTP 255 13 significantly inhibited the MPTP-mediated activation of caspase 3 and PARP (Fig. 7f,   256 g). We also demonstrated that Y-27632 significantly decreased MPTP-mediated 257 dephosphorylation of Drp1 (Ser 600) in the mouse (corresponding to Ser 637 in 258 human, Fig. 5B) (Fig. 7h) . Similarly, western blot analysis was also used to further 259 confirm that Y-27632 attenuated MPTP-induced Drp1 (Ser 600) dephosphorylation 260 and subsequently its mitochondrial translocation (Fig. 7i, j) . Taken normalized to that of the control group (100%). 375 We also detected the mitochondrial membrane potential using rhodamine 123 376 staining. Briefly, following MPP + treatment, cells were harvested and stained with 1 377 μM of rhodamine 123 in a 5% CO2 incubator for 30 min at 37 °C in the dark. 378 Subsequently, the cells were washed twice with ice-cold PBS. The fluorescence 
